全球内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场 – 行业趋势和 2030 年预测

  • Medical Devices
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Endoscopic Retrograde Cholangiopancreatography And Percutaneous Transhepatic Cholangiography Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 524.65 Million
Diagram Market Size (Forecast Year)
USD 867.96 Million
Diagram CAGR
%
Diagram Major Markets Players
  • OLYMPUS CORPORATION
  • CONMED Corporation
  • TeleMed Systems
  • Boston Scientific Corporation
  • Cook

全球内镜逆行胰胆管造影 (ERCP) 和经皮经肝胆管造影 (PTC) 设备市场,按产品类型(括约肌切开器、碎石机、内窥镜、配件、支架、套管、镊子、圈套器、导管、导丝、球囊、篮子等)、应用(黄疸、取石、术后或创伤后胆汁漏、胰腺炎等)、最终用户(医院、专科诊所、诊断实验室等)划分 - 行业趋势和预测到 2030 年。

内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场

内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场分析和规模

内镜逆行胰胆管造影设备意识的快速提升是预计会加剧内镜逆行胰胆管造影 (ERCP) 和经皮经肝胆管造影 (PTC) 设备市场增长和需求的重要因素之一。此外,全球胰腺和肝脏良性肿瘤以及阴道癌病例的增加,以及意识提升计划的增加,也有望在 2023 年至 2030 年预测期内促进全球市场的增长。

Data Bridge Market Research 分析,内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场在 2022 年的规模为 5.2465 亿美元,预计到 2030 年将达到 8.6796 亿美元,预测期内的复合年增长率可能为 3.22%。由于胆道疾病的患病率不断上升,“套管”在内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场的产品类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

内镜逆行胰胆管造影 (ERCP) 和经皮肝穿刺胆管造影 (PTC) 设备市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

OLYMPUS CORPORATION (Japan), CONMED Corporation (U.S.), TeleMed Systems, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cook (U.S.), Merit Medical Systems (U.S.), KARL STORZ SE & Co. KG (Germany), Braun Melsungen AG (Germany), BD (Becton, Dickinson and Company) (U.S.), FUJIFILM Corporation (Japan), Medtronic (Ireland), HOBBS MEDICAL, INC. (U.S.), SureCare (U.S.), Richard Wolf GmbH (Germany), PENTAX Medical (HOYA Corporation) (Japan), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Karl Storz Endoscopy-America, Inc. (U.S.), Olympus Medical Systems (Japan)

Market Opportunities

  • Significant growth potential in emerging markets
  • Collaborations and partnerships

Market Definition

An endoscopic retrograde cholangiopancreatography (ERCP) device usually utilizes a combination of fluoroscopic imaging and luminal endoscopy for the diagnosis and treatment of pancreaticobiliary system associated disorders. Percutaneous transhepatic cholangiography (PTC) is a type of therapeutic technique used to observe the anatomy of the biliary duct.

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Dynamics

Drivers

  • Growing Prevalence of Biliary Disorders

The increasing incidence of biliary disorders such as gallstones, bile duct obstructions, and pancreatitis is driving the demand for ERCP and PTC devices for diagnosis and treatment.

  • Advancements in Technology

Technological advancements in endoscopy and imaging techniques have improved the effectiveness and safety of ERCP and PTC procedures, leading to increased adoption.

Opportunities

  • Emerging Markets

There is significant growth potential in emerging markets where there is an increasing focus on improving healthcare infrastructure and access to advanced medical technologies.

Restraints/Challenges

  • High Cost of Devices

The cost of ERCP and PTC devices can be relatively high, which can limit their adoption in certain healthcare settings with budget constraints.

  • Complications and Risks

ERCP and PTC procedures carry certain risks and complications, including bleeding, infection, and pancreatitis, which may deter some patients and physicians from opting for these procedures.

  • Regulatory Challenges

Compliance with regulatory requirements and obtaining approvals for new devices can pose challenges for manufacturers in the ERCP and PTC device market.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Scope

The global endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product Type

  • Sphincterotomes
  • Lithotripter
  • Endoscopes
  •  Accessories
  • Stents
  • Cannulas
  • Forceps
  • Snares
  • Catheters
  • Guiding Wires
  • Balloons
  • Baskets
  • Others

Application

  • Jaundice
  • Stone Removal
  • Postoperative or Posttraumatic Bile Leakage
  • Pancreatitis
  • Others

End-User

  • Jaundice
  • Stone Removal
  • Postoperative or Posttraumatic Bile Leakage
  • Pancreatitis
  • Others

Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Regional Analysis/Insights

The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is analysed and market size insights and trends are provided by product type, application and end-user as referenced above.

The countries covered in the global endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.

North America dominates the endoscopic retrograde cholangiopancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC) devices market due to rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.

Asia-Pacific is the expected region in terms of growth in endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market due to rise in the prevalence of pediatric genetic diseases in this region.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Share Analysis

The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market.

Some of the major players operating in the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market are:

  • OLYMPUS CORPORATION (Japan)
  • CONMED Corporation (U.S.)
  • TeleMed Systems, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Cook (U.S.)
  • Merit Medical Systems (U.S.)
  • KARL STORZ SE & Co. KG (Germany)
  • Braun Melsungen AG (Germany)
  • BD (Becton, Dickinson and Company) (U.S.)
  • FUJIFILM Corporation (Japan)
  • Medtronic (Ireland)
  • HOBBS MEDICAL, INC. (U.S.)
  • SureCare (U.S.)
  • Richard Wolf GmbH (Germany)
  • PENTAX Medical (HOYA Corporation) (Japan)
  • Johnson & Johnson (U.S.)
  • Stryker Corporation (U.S.)
  • Smith & Nephew plc (U.K.)
  • Karl Storz Endoscopy-America, Inc. (U.S.)
  • Olympus Medical Systems (Japan)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, By Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others) - Industry Trends and Forecast to 2030. .
The Global Endoscopic Retrograde Cholangiopancreatography And Percutaneous Transhepatic Cholangiography Devices Market size was valued at USD 524.65 USD Million in 2022.
The Global Endoscopic Retrograde Cholangiopancreatography And Percutaneous Transhepatic Cholangiography Devices Market is projected to grow at a CAGR of 3.22% during the forecast period of 2023 to 2030.
The major players operating in the market include OLYMPUS CORPORATION, CONMED Corporation, TeleMed Systems, Boston Scientific Corporation, Cook, Merit Medical Systems, KARL STORZ SE & Co. KG, Braun Melsungen AG, BD, FUJIFILM Corporation, Medtronic, HOBBS MEDICAL, SureCare, Richard Wolf GmbH, PENTAX Medical, Johnson & Johnson, Stryker Corporation, Smith & Nephew plc, Karl Storz Endoscopy, Olympus Medical Systems.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.